Early- and Late-Onset Preeclampsia: A Comprehensive Cohort Study of Laboratory and Clinical Findings according to the New ISHHP Criteria

Table 5

Adverse conditions and severe complications in women with early-onset and late-onset preeclampsia.

Organ system affected	EOP (n = 113)		LOP (n = 101)
	Adverse conditions	Severe complications	Adverse conditions	Severe complications	Adverse conditions	Severe complications
CNS, n (%)	3 (2.6)	17 (15.0)	1 (1.0)	7 (7.0)	ns	ns
Cardiorespiratory, n (%)	2 (1.7)	34 (30.0)	1 (1.0)	2 (2.0)	ns	<0.0001
Hematological, n (%)	37 (32.7)	24 (21.2)	29 (29.0)	9 (9.0)	ns	0.0127
Renal, n (%)	15 (13.2)	2 (1.7)	8 (8.0)	1 (1.0)	ns	ns
Hepatic, n (%)	15 (13.2)	0 (0.0)	8 (8.0)	0 (0.0)	ns	ns
Fetoplacental, n (%)	87 (77.0)	21 (18.5)	42 (42.0)	3 (3.0)	<0.0001	0.0003

CNS, central nervous system; EOP, early-onset preeclampsia; LOP, late-onset preeclampsia; ns, nonstatistically significant.